MedPath

Add on effect of Nasya Karma with Interferential Therapy in the management of Manyastambha (Cervical Spondylosis)

Phase 1
Conditions
Health Condition 1: M479- Spondylosis, unspecified
Registration Number
CTRI/2022/05/042388
Lead Sponsor
Dr Upasana Narania
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Selection of the patients will be done irrespective of sex, socio-economic status

2.Patients of age group between 20 to 60 years

3.Patients with written consent

4. Patients who are indicated for Nasya and Interferential Therapy

5.Patients having symptoms of Manyastambha i.e. pain, stiffness, immobility in the back of the neck

Exclusion Criteria

1.Patients below 20 years and above 60 years will be excluded.

2.Pregnant women and lactating mothers will be excluded

3.Patients continuing any other medication for Manyastambha

4.Patients contraindicated for Nasya and Interferential Therapy

5.Patients who are intolerant to heat will be excluded

6. Patients suffering/under medication for any other serious illness(Patients with pacemakers,Diabetes,Hypertension,Heart Diseases, Radiculopathy,Any shoulder pathology)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in symptoms of Manyastambha i.e. pain, stiffness, rigidity, immobility in back of the neckTimepoint: 7th day, 15th day, 30th day
Secondary Outcome Measures
NameTimeMethod
Improvement in movements of the neckTimepoint: 7th day, 15th day, 30th day
© Copyright 2025. All Rights Reserved by MedPath